Iovance Biotherapeutics logo

Vice President, Research

Iovance Biotherapeutics

Tampa, FL; Philadelphia, PAHybridPosted 1 day ago
Full TimeDirector & AboveResearch & ScientistBiotechnology
Original posting ↗

Summary

The Vice President, Research will provide strategic and operational leadership across translational sciences, platform research, bioinformatics, and preclinical research activities supporting Iovance's tumor infiltrating lymphocyte (TIL) therapy platform and next-generation cellular immunotherapy pipeline. Reporting to the Executive Vice President, Translational Medicine & Research, the VP, Research will advance discovery and translational research programs, drive IND-enabling activities, and expand the scientific foundation of Iovance's cellular therapy platforms.

Job description

Overview

The Vice President, Research will provide strategic and operational leadership across translational sciences, platform research, bioinformatics, and preclinical research activities supporting Iovance's tumor infiltrating lymphocyte (TIL) therapy platform and next-generation cellular immunotherapy pipeline. Reporting to the Executive Vice President, Translational Medicine & Research, the VP, Research will advance discovery and translational research programs, drive IND-enabling activities, and expand the scientific foundation of Iovance's cellular therapy platforms.

Scientific & Strategic Leadership

  • Lead and oversee translational sciences, platform research, bioinformatics, and preclinical research functions supporting the TIL therapy and immuno-oncology pipeline.
  • Partner closely with the EVP, Translational Medicine & Research to define and execute research strategy aligned with corporate and pipeline objectives.
  • Advance next-generation cellular therapy approaches through innovation in tumor immunology, immune cell engineering, and translational biology.
  • Drive scientific rigor, innovation, and operational excellence across research and translational programs.

Translational Sciences & IND-Enabling Research

  • Lead translational medicine strategies supporting biomarker discovery, patient selection, mechanism-of-action studies, and translational endpoints.
  • Oversee IND-enabling research activities, including preclinical pharmacology, proof-of-concept studies, and translational data packages supporting regulatory submissions.
  • Ensure effective integration of translational findings into clinical development strategies and decision-making.
  • Collaborate with Regulatory, Clinical Development, and CMC teams to support successful advancement of programs into clinical trials.

Platform & Preclinical Research Leadership

  • Provide scientific leadership for platform research initiatives focused on advancing and differentiating cellular therapy technologies.
  • Oversee preclinical research activities supporting pipeline expansion and next-generation platform innovation.
  • Guide evaluation and implementation of emerging technologies relevant to cell therapy, protein sciences, bioinformatics, and viral/vector-related approaches.

Bioinformatics & Computational Biology

  • Lead bioinformatics and computational biology capabilities supporting genomic, transcriptomic, proteomic, and multi-omic analyses.
  • Ensure computational and translational insights are integrated into research strategy, target identification, biomarker development, and clinical translation.

Cross-Functional Collaboration

  • Collaborate closely with Clinical Development, Technical Operations, Manufacturing, Regulatory Affairs, and CMC teams to advance programs from discovery through early clinical development.
  • Contribute scientific leadership to portfolio prioritization, governance discussions, and external partnership evaluations.
  • Support diligence activities and scientific assessments for external collaborations and platform opportunities.

Team Leadership & Organizational Development

  • Build, mentor, and lead high-performing multidisciplinary scientific teams.
  • Foster a culture of innovation, accountability, collaboration, and scientific excellence.
  • Recruit and retain top scientific talent within a fast-paced and evolving biotechnology environment.

External Scientific Engagement

  • Represent Iovance within the scientific and medical community through publications, conferences, scientific advisory interactions, and external collaborations.
  • Maintain awareness of scientific and competitive developments across cell therapy, immuno-oncology, and translational medicine landscapes.

Requirements

  • PhD, MD, or MD/PhD in Immunology, Oncology, Molecular Biology, Cell Biology, Bioengineering, or related scientific discipline required
  • 15+ years of biotechnology or pharmaceutical industry experience with progressive scientific leadership responsibilities
  • Significant experience in cell therapy, immuno-oncology, or advanced therapeutic modalities
  • Demonstrated leadership of translational sciences, preclinical research, and IND-enabling programs supporting oncology therapeutics
  • Deep scientific expertise in tumor immunology, translational medicine, and cellular therapy research
  • Experience overseeing or closely partnering with bioinformatics and computational biology functions
  • Knowledge of viral vector technologies, engineered cell therapies, and protein sciences strongly preferred
  • Prior experience with TIL, TCR, CAR-T, NK cell, or other adoptive cellular therapy platforms highly desirable
  • Proven track record advancing discovery and preclinical programs into clinical development
  • Experience leading multidisciplinary scientific organizations within a dynamic biotechnology environment

Company overview

Iovance Biotherapeutics is a pioneering biotechnology company focused on developing innovative tumor infiltrating lymphocyte (TIL) therapies for cancer treatment. Founded in 2007 and headquartered in San Carlos, California, the company aims to be the global leader in innovating, developing, and delivering personalized cell therapies for patients with cancer. Iovance's transformational approach harnesses the human immune system's ability to recognize and attack diverse cancer cells in each patient through their proprietary TIL platform. The company's lead investigational therapy, lifileucel, has demonstrated promising clinical data across multiple solid tumors including melanoma, cervical cancer, and non-small cell lung cancer. Iovance operates a state-of-the-art 136,000-square-foot Cell Therapy Center in Philadelphia for manufacturing their therapies using proprietary good manufacturing practices. As a publicly traded company (NASDAQ: IOVA), Iovance maintains a patient-centric, collaborative culture with a workforce of 501-1,000 employees dedicated to advancing next-generation cancer immunotherapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.